PERSPECTA

News from every angle

Results for "RBC Capital Markets"

30 stories found

RBC Trims Price Targets for ACADIA, Galapagos
FinanceYahoo15d ago

RBC Trims Price Targets for ACADIA, Galapagos

RBC Capital Markets has slightly trimmed its price target for ACADIA Pharmaceuticals, citing seasonal biotech headwinds. The firm also cut its price target for Galapagos NV to $28, while maintaining a Sector Perform rating ahead of its Q1 earnings.